NCT04495088 2026-02-02
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
Universitätsmedizin Mannheim
Phase 3 Recruiting
Clinical Trials
4 trialsNCT07132463 2025-08-20
Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
Fudan University
Phase 3 Not yet recruiting
NCT03671252 2019-01-23
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
Sun Yat-sen University
Phase 3 Recruiting
NCT03038217 2017-02-03
Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer
Peking Union Medical College Hospital
Phase 3 Unknown